Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:18 PM
Study NCT ID:
NCT05506956
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2022-08-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Post-transplant Flotetuzumab for AML
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-16
First Submit QC Date:
None
Study First Post Date:
2022-08-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-25
Results First Submit QC Date:
None
Results First Post Date:
2025-09-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-22
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED